Literature DB >> 20513411

Molecular dynamics simulations of anti-aggregation effect of ibuprofen.

Wenling E Chang1, Takako Takeda, E Prabhu Raman, Dmitri K Klimov.   

Abstract

Using implicit solvent molecular dynamics and replica exchange simulations, we study the impact of ibuprofen on the growth of wild-type Abeta fibrils. We show that binding of ibuprofen to Abeta destabilizes the interactions between incoming peptides and the fibril. As a result, ibuprofen interference modifies the free energy landscape of fibril growth and reduces the free energy gain of Abeta peptide binding to the fibril by approximately 2.5 RT at 360 K. Furthermore, ibuprofen interactions shift the thermodynamic equilibrium from fibril-like locked states to disordered docked states. Ibuprofen's anti-aggregation effect is explained by its competition with incoming Abeta peptides for the same binding site located on the fibril edge. Although ibuprofen impedes fibril growth, it does not significantly change the mechanism of fibril elongation or the structure of Abeta peptides bound to the fibril. Copyright (c) 2010 Biophysical Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20513411      PMCID: PMC2877328          DOI: 10.1016/j.bpj.2010.02.031

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  47 in total

Review 1.  Protein folding and misfolding.

Authors:  Christopher M Dobson
Journal:  Nature       Date:  2003-12-18       Impact factor: 49.962

2.  Kinetic analysis of beta-amyloid fibril elongation.

Authors:  Michelle J Cannon; Angela D Williams; Ronald Wetzel; David G Myszka
Journal:  Anal Biochem       Date:  2004-05-01       Impact factor: 3.365

3.  Replica exchange molecular dynamics simulations of amyloid peptide aggregation.

Authors:  M Cecchini; F Rao; M Seeber; A Caflisch
Journal:  J Chem Phys       Date:  2004-12-01       Impact factor: 3.488

Review 4.  Probing the pressure-temperature stability of amyloid fibrils provides new insights into their molecular properties.

Authors:  Filip Meersman; Christopher M Dobson
Journal:  Biochim Biophys Acta       Date:  2005-11-16

5.  Probing energetics of Abeta fibril elongation by molecular dynamics simulations.

Authors:  Takako Takeda; Dmitri K Klimov
Journal:  Biophys J       Date:  2009-06-03       Impact factor: 4.033

6.  Acute treatment with the PPARgamma agonist pioglitazone and ibuprofen reduces glial inflammation and Abeta1-42 levels in APPV717I transgenic mice.

Authors:  Michael T Heneka; Magdalena Sastre; Lucia Dumitrescu-Ozimek; Anne Hanke; Ilse Dewachter; Cuno Kuiperi; Kerry O'Banion; Thomas Klockgether; Fred Van Leuven; Gary E Landreth
Journal:  Brain       Date:  2005-04-07       Impact factor: 13.501

7.  Dynamics of locking of peptides onto growing amyloid fibrils.

Authors:  Govardhan Reddy; John E Straub; D Thirumalai
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-06       Impact factor: 11.205

8.  Non-steroidal anti-inflammatory drugs have anti-amyloidogenic effects for Alzheimer's beta-amyloid fibrils in vitro.

Authors:  Mie Hirohata; Kenjiro Ono; Hironobu Naiki; Masahito Yamada
Journal:  Neuropharmacology       Date:  2005-08-25       Impact factor: 5.250

Review 9.  The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics.

Authors:  John Hardy; Dennis J Selkoe
Journal:  Science       Date:  2002-07-19       Impact factor: 47.728

10.  Ibuprofen reduces Abeta, hyperphosphorylated tau and memory deficits in Alzheimer mice.

Authors:  Ann C McKee; Isabel Carreras; Lokman Hossain; Hoon Ryu; William L Klein; Salvatore Oddo; Frank M LaFerla; Bruce G Jenkins; Neil W Kowall; Alpaslan Dedeoglu
Journal:  Brain Res       Date:  2008-02-16       Impact factor: 3.252

View more
  7 in total

1.  Nonsteroidal anti-inflammatory drug naproxen destabilizes Aβ amyloid fibrils: a molecular dynamics investigation.

Authors:  Takako Takeda; Rashmi Kumar; E Prabhu Raman; Dmitri K Klimov
Journal:  J Phys Chem B       Date:  2010-10-27       Impact factor: 2.991

2.  Naproxen interferes with the assembly of Aβ oligomers implicated in Alzheimer's disease.

Authors:  Seongwon Kim; Wenling E Chang; Rashmi Kumar; Dmitri K Klimov
Journal:  Biophys J       Date:  2011-04-20       Impact factor: 4.033

3.  Binding of nonsteroidal anti-inflammatory drugs to Abeta fibril.

Authors:  Takako Takeda; Wenling E Chang; E Prabhu Raman; Dmitri K Klimov
Journal:  Proteins       Date:  2010-10

4.  Molecular interactions of Alzheimer's biomarker FDDNP with Aβ peptide.

Authors:  Christopher Lockhart; Dmitri K Klimov
Journal:  Biophys J       Date:  2012-12-05       Impact factor: 4.033

5.  Molecular modeling to investigate the binding of Congo red toward GNNQQNY protofibril and in silico virtual screening for the identification of new aggregation inhibitors.

Authors:  Jian-Hua Zhao; Hsuan-Liang Liu; Pavadai Elumalai; Wei-Hsi Chen; Lee-Chung Men; Kung-Tien Liu
Journal:  J Mol Model       Date:  2012-07-27       Impact factor: 1.810

Review 6.  The role of molecular simulations in the development of inhibitors of amyloid β-peptide aggregation for the treatment of Alzheimer's disease.

Authors:  Justin A Lemkul; David R Bevan
Journal:  ACS Chem Neurosci       Date:  2012-08-27       Impact factor: 4.418

7.  Computational design of new Peptide inhibitors for amyloid Beta (aβ) aggregation in Alzheimer's disease: application of a novel methodology.

Authors:  Gözde Eskici; Mert Gur
Journal:  PLoS One       Date:  2013-06-06       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.